ロード中...
Rosiglitazone treatment restores renal responsiveness to atrial natriuretic peptide in rats with congestive heart failure
The thiazolidinedione (TZD) class of Peroxisome proliferator‐activated receptor gamma agonists has restricted clinical use for diabetes mellitus due to fluid retention and potential cardiovascular risks. These side effects are attributed in part to direct salt‐retaining effect of TZDs at the renal c...
保存先:
| 出版年: | J Cell Mol Med |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6584517/ https://ncbi.nlm.nih.gov/pubmed/31087547 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.14366 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|